Last reviewed · How we verify
NCT06263686: YASI-03
Evaluation of the Effects of Routine Intake of Fresh vs- Pasteurized Yoghurt on the Immune System in Healthy Adults
NA trial testing Pasteurised yoghurt in Immune System in 125 participants. Completed in 31 December 2016.
1 November 2016
Quick facts
| Lead sponsor | University of Valladolid |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 125 |
| Start date | 1 June 2016 |
| Primary completion | 1 November 2016 |
| Estimated completion | 31 December 2016 |
Drugs / interventions tested
- Pasteurised yoghurt
- Fresh yoghurt
- Sterilised yoghurt
Conditions studied
- Immune System — all drugs for Immune System →
- Innate Inflammatory Response — all drugs for Innate Inflammatory Response →
Sponsor
University of Valladolid
Who can join
Adults 20 to 70, any sex, with Immune System or Innate Inflammatory Response. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, the purpose was to describe and compare the modulator effects on the immune system of the routine ingestion of fresh vs. pasteurized yoghurt. A unicentral, prospective, randomized, double-blind, parallel group nutritional study for 8 weeks was carried out comparing the ingestion of 125 g (three times a day) of the products in healthy adults. A complete battery of in vitro tests on the activity of immune system, processes and phenomena was performed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06263686
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Immune System
Currently open trials in the same condition.
- NCT07020156 — A First-in-Human Phase I Trial of OX118 in Healthy Volunteers · Phase 1 · recruiting
- NCT06470607 — The Lymphocytic Infiltrate of Lung Tumors. · recruiting
- NCT05334888 — Sex-differential Host-microbiome CVD Risk - A Longitudinal Cohort Approach · recruiting
- NCT06683248 — The Effects of Night Shift Work on Health Across the Menstrual Cycle · NA · recruiting
- NCT05026242 — Effects of Almond Consumption on Innate and Adaptive Immune System · NA · active not recruiting
Other University of Valladolid trials
Trials by the same sponsor.
- NCT07302191 — High-Intensity Interval or Concurrent Exercise on Oxidative Stress and Inflammation in Obese Women · NA · completed
- NCT07307391 — Exercise in Extreme Hot Weather Conditions · NA · completed
- NCT06696378 — Melatonin Supplementation and Exercise Program in Breast Cancer Women · NA · recruiting
- NCT06616181 — TDCS and Tele-rehabilitation Exercise in Fibromyalgia · NA · not yet recruiting
- NCT06326229 — Clinical Validation of Musculoskeletal ICF Core Set in Primary Care Physiotherapy · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06263686 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Valladolid
- Last refreshed: 6 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06263686.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing